NCT04370262: A trial that was reported late by Northwell Health
This trial has reported, although it was 161 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04370262 |
|---|---|
| Title | A Multi-site, Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Standard of Care (SOC) Plus Famotidine vs SOC Plus Placebo for the Treatment of COVID-19 in Hospitalized Adults |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 7, 2020 |
| Completion date | Sept. 7, 2020 |
| Required reporting date | Sept. 7, 2021, midnight |
| Actual reporting date | Feb. 15, 2022 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | 161 |